SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gennex Laboratories informs about outcome of board meeting

04 Jul 2025 Evaluate

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, Gennex Laboratories has informed that Board of Directors of the Company, at its meeting held today, on July 04, 2025 has considered and approved the following: Allotment of 60,00,000 Equity Shares upon Conversion of Warrants to the member of promoter group on Preferential basis. The requisite disclosures are set out in Annexure A to this letter. The Board Meeting had commenced at 02:00 pm and concluded at 02.40 pm. This intimation is also uploaded on the Company website: www.gennexlab.com.

The above information is a part of company’s filings submitted to BSE.

Gennex Lab Share Price

10.21 0.21 (2.10%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×